QuickView for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=84A7B1B8F90E10C4BB8EF198E8862C87;jsessionid=086624F9ED561E2247AC960DF604F403;jsessionid=47BD8608FF341F1D3328BD9EEC561979;jsessionid=A043B438A3B5591667B8740B38982408;jsessionid=D6ACA0349E5D82D5BF0C120CA3306CD5;jsessionid=7DA3A957A66677480F5DF364BC503BEC;jsessionid=AA6EFFCD497823B4B83F829372C165C1;jsessionid=BC1CAF9FB909B9B1623A6E8562F03DF2 (gene)

1. Ataxin-2 sequesters Raptor into aggregates and impairs cellular mTORC1 signaling.
2. ATXN2 is a target of N-terminal proteolysis.
3. ATXN2 intermediate expansions in amyotrophic lateral sclerosis.
4. TDP-43 impairs sleep in Drosophila through Ataxin-2-dependent metabolic disturbance.
5. Missense mutation in ATXN2 gene (c.2860C > T) in an amyotrophic lateral sclerosis patient with aggre…

There were no clinical trials for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=84A7B1B8F90E10C4BB8EF198E8862C87;jsessionid=086624F9ED561E2247AC960DF604F403;jsessionid=47BD8608FF341F1D3328BD9EEC561979;jsessionid=A043B438A3B5591667B8740B38982408;jsessionid=D6ACA0349E5D82D5BF0C120CA3306CD5;jsessionid=7DA3A957A66677480F5DF364BC503BEC;jsessionid=AA6EFFCD497823B4B83F829372C165C1;jsessionid=BC1CAF9FB909B9B1623A6E8562F03DF2